Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Retina (Philadelphia, Pa.)
|
October 8, 2013
Hemorrhagic unilateral retinopathy
Veronica A Kon Graversen, Lee M Jampol, Travis Meredith, et al.
The British Journal of Ophthalmology
|
June 23, 2018
Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial
Florentina Joyce Freiberg, Stephan Michels, Alyson Muldrew, et al.
American Journal of Ophthalmology
|
July 4, 2002
Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin
Richard F Spaide, Melissa L Martin, Jason Slakter, et al.
Ophthalmology Science
|
September 11, 2025
Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis
Chui Ming Gemmy Cheung, Timothy L Jackson, Charles C Wykoff, et al.
Retina (Philadelphia, Pa.)
|
November 21, 2002
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy
Richard F Spaide, Irene Donsoff, Deborah L Lam, et al.
JAMA Ophthalmology
|
October 12, 2013
Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration
Megan M McLaughlin, Marcella G Paglione, Jason Slakter, et al.
Retina (Philadelphia, Pa.)
|
March 28, 2012
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. 2002
Richard F Spaide, Irene Donsoff, Deborah L Lam, et al.
Retina (Philadelphia, Pa.)
|
March 28, 2012
Retinal angiomatous proliferation in age–related macular degeneration. 2001
Lawrence A Yannuzzi, Silvana Negrão, Tomohiro Iida, et al.
Retina (Philadelphia, Pa.)
|
April 11, 2006
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
Richard F Spaide, Ketan Laud, Howard F Fine, et al.
Ophthalmology
|
February 8, 2023
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration
Timothy L Jackson, Jason Slakter, Marc Buyse, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Retina (Philadelphia, Pa.)
|
October 8, 2013
Hemorrhagic unilateral retinopathy
Veronica A Kon Graversen, Lee M Jampol, Travis Meredith, et al.
The British Journal of Ophthalmology
|
June 23, 2018
Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration: findings from the INTREPID clinical trial
Florentina Joyce Freiberg, Stephan Michels, Alyson Muldrew, et al.
American Journal of Ophthalmology
|
July 4, 2002
Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin
Richard F Spaide, Melissa L Martin, Jason Slakter, et al.
Ophthalmology Science
|
September 11, 2025
Sozinibercept (Anti-VEGF-C/-D) Combined with Ranibizumab for Polypoidal Choroidal Vasculopathy: Phase IIb Predefined Subgroup Analysis
Chui Ming Gemmy Cheung, Timothy L Jackson, Charles C Wykoff, et al.
Retina (Philadelphia, Pa.)
|
November 21, 2002
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy
Richard F Spaide, Irene Donsoff, Deborah L Lam, et al.
JAMA Ophthalmology
|
October 12, 2013
Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration
Megan M McLaughlin, Marcella G Paglione, Jason Slakter, et al.
Retina (Philadelphia, Pa.)
|
March 28, 2012
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. 2002
Richard F Spaide, Irene Donsoff, Deborah L Lam, et al.
Retina (Philadelphia, Pa.)
|
March 28, 2012
Retinal angiomatous proliferation in age–related macular degeneration. 2001
Lawrence A Yannuzzi, Silvana Negrão, Tomohiro Iida, et al.
Retina (Philadelphia, Pa.)
|
April 11, 2006
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
Richard F Spaide, Ketan Laud, Howard F Fine, et al.
Ophthalmology
|
February 8, 2023
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration
Timothy L Jackson, Jason Slakter, Marc Buyse, et al.
Page
of 3